Crispr Therapeutics AG (CRSP) stock saw a decline, ending the day at $38.85 which represents a decrease of $-0.84 or -2.12% from the prior close of $39.69. The stock opened at $39.06 and touched a low ...
Check the time stamp on this data. Updated AI-Generated Signals for Crispr Therapeutics Ag (CRSP) available here: CRSP. Type ...
The fund is sponsored by Vanguard. It has amassed assets over $153.57 billion, making it one of the largest ETFs attempting to match the Large Cap Growth segment of the US equity market. Fed officials ...
If we assume all patients who began treatment with Casgevy last year progress to the administration stage, CRISPR and Vertex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback